Lycia Therapeutics Stock Jumps 67% in IPO Debut as Wall Street Backs a New Approach to Allergy Treatment ( $BBC $IBB $LYCA $XBI ) by John F. Heerdink, Jr. 2 days ago Read more Doximity’s UpToDate Deal and Amwell’s Mental Health Results Build a Bullish Case for Connected Care -( $AMWL $DOCS $DCYHY $WTKWY ) by John F. Heerdink, Jr. October 21, 2026 Read more Viking Therapeutics’ $575 Million Raise Gives Its Obesity Ambitions New Muscle -( $VKTX $IBB $XBI ) by John F. Heerdink, Jr. October 20, 2026 Read more Biotech Bulls Find Fresh Fuel as Disc Medicine, Arcutis and Parabilis Advance Their Investment Cases -( $ARQT $BBC $IRON $PBLS ) by John F. Heerdink, Jr. October 19, 2026 Read more Merck’s $1.3 Billion Silence Deal Puts Precision Biotech in Focus as Serina and Eupraxia Advance -( $BBC $EPRX $IBB $MKKGY $MRK $SER $SLN $XBI ) by John F. Heerdink, Jr. October 19, 2026 Read more Eupraxia Pharmaceuticals Hits RESOLVE Enrollment Target as December EoE Data Come Into Focus -( $EPRX $XBI $IBB ) by John F. Heerdink, Jr. October 16, 2026 Read more Modular Medical’s Road to Revenue: Why $MODD’s Pivot Launch Is Becoming a Story Worth Watching -( by John F. Heerdink, Jr. October 16, 2026 Read more Eupraxia: Three Bullish Analyst Reports Put EP-104GI’s EoE Opportunity in Focus Post Tezspire Results -( $AMGN $APGE $AZN $EPRX $REGN $SNY $TAK ) by John F. Heerdink, Jr. October 12, 2026 Read more Iambic’s $150 Million IPO Puts AI Drug Discovery in Wall Street’s Spotlight -( $IAM $IBB $JNJ $LLY $NVDA $TAK $XBI ) by John F. Heerdink, Jr. October 12, 2026 Read more Multiply Labs Raises $75 Million as Physical AI Takes Aim at Biotech’s Manufacturing Bottleneck -( $AZN $KYTX $LEGN $NVS $TER ) by John F. Heerdink, Jr. October 11, 2026 Read more Read more
